Search by Drug Name or NDC
NDC 49502-0476-26 Pretomanid 200 mg/1 Details
Pretomanid 200 mg/1
Pretomanid is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Specialty L.P.. The primary component is PRETOMANID.
MedlinePlus Drug Summary
Pretomanid is used along with bedaquiline (Sirturo) and linezolid (Zyvox) to treat multi-drug resistant tuberculosis (MDR-TB; a serious infection that affects the lungs that cannot be treated with other medications) in adults. Pretomanid is in a class of medications called antimycobacterials. It works by killing the bacteria that cause tuberculosis.
Related Packages: 49502-0476-26Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pretomanid
Product Information
| NDC | 49502-0476 |
|---|---|
| Product ID | 49502-476_5dd0a13a-c8f0-413f-8306-92c479195e0f |
| Associated GPIs | 09000063000320 |
| GCN Sequence Number | 080112 |
| GCN Sequence Number Description | pretomanid TABLET 200 MG ORAL |
| HIC3 | W1G |
| HIC3 Description | ANTITUBERCULAR ANTIBIOTICS |
| GCN | 46807 |
| HICL Sequence Number | 045940 |
| HICL Sequence Number Description | PRETOMANID |
| Brand/Generic | Generic |
| Proprietary Name | Pretomanid |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Pretomanid |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/1 |
| Substance Name | PRETOMANID |
| Labeler Name | Mylan Specialty L.P. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA212862 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 49502-0476-26 (49502047626)
| NDC Package Code | 49502-476-26 |
|---|---|
| Billing NDC | 49502047626 |
| Package | 26 TABLET in 1 BOTTLE (49502-476-26) |
| Marketing Start Date | 2019-11-07 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |